CAS 1198353-13-7|FORMOTEROL-D3
Introduction：Basic information about CAS 1198353-13-7|FORMOTEROL-D3, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | FORMOTEROL-D3 | ||
|---|---|---|---|
| CAS Number | 1198353-13-7 | Molecular Weight | 347.42 |
| Density | / | Boiling Point | / |
| Molecular Formula | C19H21D3N2O4 | Melting Point | / |
| MSDS | / | Flash Point | / |
Names
| Name | FORMOTEROL-D3 |
|---|
FORMOTEROL-D3 BiologicalActivity
| Description | Formoterol-d3 is deuterium labeled Arformoterol. Arformoterol ((R,R)-Formoterol), the (R,R)-enantiomer of Formoterol, is a long-acting β2-adrenergic receptor (β2-AR) agonist, with a Kd of 2.9 nM. Arformoterol can be used for the research of chronic obstructive pulmonary disease (COPD)[1][2]. |
|---|---|
| Related Catalog | Signaling Pathways >>GPCR/G Protein >>Adrenergic ReceptorResearch Areas >>Inflammation/Immunology |
| In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1]. |
| References | [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [2]. Handley DA, et, al. Biological actions of formoterol isomers. Pulm Pharmacol Ther. 2002;15(2):135-45. [3]. Cazzola M, et, al. Arformoterol tartrate in the treatment of COPD. Expert Rev Respir Med. 2010 Apr;4(2):155-62. [4]. Song W, et, al. Postexposure administration of a {beta}2-agonist decreases chlorine-induced airway hyperreactivity in mice. Am J Respir Cell Mol Biol. 2011 Jul;45(1):88-94. |
Chemical & Physical Properties
| Molecular Formula | C19H21D3N2O4 |
|---|---|
| Molecular Weight | 347.42 |
